← Back to companies
Idexx Laboratories
IDXXHealthcareNMS$46.0B
IDXX SEC filings last scanned 4 Oct 2026, 19:05 UTC
CEO Timeline
Michael (Mike) EricksonCurrent
May 2026 — Present(5mo)
Michael Erickson was appointed President and Chief Executive Officer of IDEXX Laboratories, effective May 12, 2026, succeeding Jonathan Mazelsky.
2 source filings — click to expand
Jay MazelskyInterim
Jun 2019 — May 2026(6y 11mo)
Jay Mazelsky was appointed Interim President and Chief Executive Officer of IDEXX Laboratories, effective June 28, 2019, succeeding Jonathan W. Ayers.
stepped down to retire from the Company and the Board (to retire fully in May 2027)
4 source filings — click to expand
Jonathan W. Ayers
Since at least Mar 2005 — Jun 2019(14y 3mo)
serious bicycling accident on June 27, 2019 resulting in severe spinal cord injury
3 source filings — click to expand